StockData
Ingevity Corp logo

Ingevity Corp (NGVT) stock

NGVTNYSEChemicals & Allied ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3077% above fair value
$60.02−1.70 (-2.75%)

Close on Nov 16, 2026Market cap $2.06BP/E 40.8Yield –

Ingevity r&d expenses

Research and development expenses are spending on new products and technology.

Ingevity's R&D Expenses for the twelve months ending Jun 30, 2026 was $27.20M, up 1.9% year over year. For fiscal 2025 it was $28.40M, up 15.9% from the year before. Over ten years it grew 5.0% a year on average. The highest annual figure on record is $30.30M in fiscal 2022.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$28.40M+15.9%
FY2024Dec 31, 2024$24.50M-3.5%
FY2023Dec 31, 2023$25.40M-16.2%
FY2022Dec 31, 2022$30.30M+15.2%
FY2021Dec 31, 2021$26.30M+16.4%
FY2020Dec 31, 2020$22.60M+14.7%
FY2019Dec 31, 2019$19.70M-8.4%
FY2018Dec 31, 2018$21.50M+8.6%
FY2017Dec 31, 2017$19.80M+12.5%
FY2016Dec 31, 2016$17.60M+1.1%
FY2015Dec 31, 2015$17.40M+123.1%
FY2014Dec 31, 2014$7.80M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$6.10M-12.9%
Q1 FY2026Mar 31, 2026$6.70M-4.3%
Q4 FY2025Dec 31, 2025$7.40M+13.8%
Q3 FY2025Sep 30, 2025$7.00M+12.9%
Q2 FY2025Jun 30, 2025$7.00M-4.1%
Q1 FY2025Mar 31, 2025$7.00M+2.9%
Q4 FY2024Dec 31, 2024$6.50M+712.5%
Q3 FY2024Sep 30, 2024$6.20M-20.5%
Q2 FY2024Jun 30, 2024$7.30M-8.8%
Q1 FY2024Mar 31, 2024$6.80M-22.7%
Q4 FY2023Dec 31, 2023$800.00K-88.9%
Q3 FY2023Sep 30, 2023$7.80M+2.6%
Q2 FY2023Jun 30, 2023$8.00M-2.4%
Q1 FY2023Mar 31, 2023$8.80M+20.5%
Q4 FY2022Dec 31, 2022$7.20M+2.9%
Q3 FY2022Sep 30, 2022$7.60M+11.8%
Q2 FY2022Jun 30, 2022$8.20M+39.0%
Q1 FY2022Mar 31, 2022$7.30M+10.6%
Q4 FY2021Dec 31, 2021$7.00M+20.7%
Q3 FY2021Sep 30, 2021$6.80M+30.8%
Q2 FY2021Jun 30, 2021$5.90M+9.3%
Q1 FY2021Mar 31, 2021$6.60M+6.5%
Q4 FY2020Dec 31, 2020$5.80M+23.4%
Q3 FY2020Sep 30, 2020$5.20M+6.1%
Q2 FY2020Jun 30, 2020$5.40M+8.0%
Q1 FY2020Mar 31, 2020$6.20M+21.6%
Q4 FY2019Dec 31, 2019$4.70M-9.6%
Q3 FY2019Sep 30, 2019$4.90M-12.5%
Q2 FY2019Jun 30, 2019$5.00M-5.7%
Q1 FY2019Mar 31, 2019$5.10M+2.0%
Q4 FY2018Dec 31, 2018$5.20M0.0%
Q3 FY2018Sep 30, 2018$5.60M+16.7%
Q2 FY2018Jun 30, 2018$5.30M+12.8%
Q1 FY2018Mar 31, 2018$5.00M-2.0%
Q4 FY2017Dec 31, 2017$5.20M+18.2%
Q3 FY2017Sep 30, 2017$4.80M+23.1%
Q2 FY2017Jun 30, 2017$4.70M–
Q1 FY2017Mar 31, 2017$5.10M–
Q4 FY2016Dec 31, 2016$4.40M–
Q3 FY2016Sep 30, 2016$3.90M–

More Ingevity figures

See a number that looks wrong?